September 5, 2024 | Media, News
Progressive neurological illness characterised by episodic deterioration has been observed and documented since the late 1300s. In the mid-19th century, multiple sclerosis (MS) was described as an identifiable entity based on its pathology (Murray, 2009). Since then, the process of diagnosing MS has evolved with a greater understanding of the pathology and advances in diagnostic tests available. The internationally recognised criteria for diagnosing MS currently used in Aotearoa New Zealand, the 2017, McDonald Criteria were first established in 2001. It has since undergone three revisions driven by the advancement of MRI technology, leading to earlier diagnosis (McNicholas et al., 2018).
Read our full article in the latest edition of GP Voice below.